Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 01, 2015 3:22 AM ET

Biotechnology

Company Overview of QLT Inc.

Executive Profile

Geoffrey F. Cox Ph.D., BSc

Interim Chief Executive Officer and Director, QLT Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 7 different industries.

See Board Relationships
72$475,262
As of Fiscal Year 2014

Background

Dr. Geoffrey F. Cox, Ph.D., BSc has been an Interim Chief Executive Officer of QLT Inc. since October 23, 2014. Dr. Cox serves as a Partner at Red Sky Partners LLC. Dr. Cox serves as an Independent Consultant to the Biotechnology and Life Sciences Industry and Principal of Beacon Street Advisors. Dr. Cox served as Chairman, Chief Executive Officer and President of rEVO Biologics (formerly, GTC Biotherapeutics Inc.) from July 2001 to June 15, 2010. Dr. Cox served as the ...

Corporate Headquarters

887 Great Northern Way
Vancouver, British Columbia V5T 4T5

Canada

Phone: 604-707-7000
Fax: 604-707-7001

Board Members Memberships

Former Chairman of the Board
Director
Non-Executive Director
Independent Director
1994-N/A
Former Chairman and Chief Executive Officer
2000-N/A
Non-Executive Chairman
2000-Present
Non-Executive Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2001-2010
Former Chairman, Chief Executive Officer and President
2012-Present
Interim Chief Executive Officer and Director
2014-Present
Director

Education

BS
University of Birmingham
PhD
University of East Anglia

Other Affiliations

Annual Compensation

Salary$94,398
Total Annual Compensation$94,398

Stocks Options

Exercisable Options$61,806
Exercisable Options Value$7,472
Unexercisable Options$113,194
Unexercisable Options Value$14,528
Total Value of Options$22,000
Total Number of Options$175,000

Total Compensation

Total Annual Cash Compensation$187,297
Total Short Term Compensation$94,398
Total Calculated Compensation$475,262
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QLT Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.